This concept aligns with the broader literature demonstrating that pancreatic cancer, traditionally viewed as an “immune-cold” tumor, contains rare but clinically meaningful pockets of immune activation characterized by Tc infiltration and IFN-γ-producing Th subsets [17,24]. The gene discussed is IFNG; the disease is pancreatic neoplasm.